Spyre Therapeutics (SYRE) Preferred Shares Issued (2023 - 2024)
Spyre Therapeutics' Preferred Shares Issued history spans 3 years, with the latest figure at -$169.2 million for Q2 2024.
- For Q2 2024, Preferred Shares Issued changed N/A year-over-year to -$169.2 million; the TTM value through Sep 2024 reached $197.4 million, changed N/A, while the annual FY2023 figure was $197.4 million, N/A changed from the prior year.
- Preferred Shares Issued reached -$169.2 million in Q2 2024 per SYRE's latest filing, down from $169.2 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $197.4 million in Q4 2023 to a low of -$169.2 million in Q2 2024.